Difficulty: Medium
Average Score: 87%
Practice
Though bromocriptine acts directly on dopamine receptors, it is used in parkinsonism only as a supplement to levodopa because
Correct answer
C
Rationale
In the treatment of parkinsonism, bromocriptine is used as a supplement to levodopa because when used alone, its effective doses produce intolerable side effects. This is the correct answer (Option C) because bromocriptine, a dopamine receptor agonist, can lead to adverse effects such as nausea, vomiting, dizziness, and hallucinations when used at doses required for efficacy in treating Parkinson's disease.
Option A (low efficacy) is incorrect because bromocriptine does have efficacy in targeting dopamine receptors, but the issue lies in the side effect profile when used at effective doses. Option B (first dose hypotension) is incorrect as this side effect is typically associated with other medications like dopamine agonists used in Parkinson's disease. Option D (therapeutic effect takes a long time to develop) is incorrect as bromocriptine can have a relatively quick onset of action due to its direct action on dopamine receptors.
Educationally, it is important for healthcare providers to understand the rationale behind using bromocriptine as an adjunct to levodopa in the treatment of parkinsonism to optimize patient outcomes and minimize side effects. Understanding the pharmacological properties of CNS drugs like bromocriptine can help healthcare professionals make informed decisions in clinical practice.
Option A (low efficacy) is incorrect because bromocriptine does have efficacy in targeting dopamine receptors, but the issue lies in the side effect profile when used at effective doses. Option B (first dose hypotension) is incorrect as this side effect is typically associated with other medications like dopamine agonists used in Parkinson's disease. Option D (therapeutic effect takes a long time to develop) is incorrect as bromocriptine can have a relatively quick onset of action due to its direct action on dopamine receptors.
Educationally, it is important for healthcare providers to understand the rationale behind using bromocriptine as an adjunct to levodopa in the treatment of parkinsonism to optimize patient outcomes and minimize side effects. Understanding the pharmacological properties of CNS drugs like bromocriptine can help healthcare professionals make informed decisions in clinical practice.